Close
Close

Characterization

Characterization

Affinity may look great—but what about sequence integrity, developability, or immunogenicity? At Creative Biolabs, we go beyond surface-level data to decode your antibody’s full identity. Whether you're preparing for IND or just need to weed out a weak binder early, our comprehensive characterization services give you confidence with clarity.

De Novo Antibody Sequencing

De Novo Antibody Sequencing Infographic. Fig.1 Download

Why Thorough Characterization Matters

Even the strongest binding doesn’t guarantee success. Imagine an antibody with excellent affinity in ELISA but low developability due to thermal instability. Or one that’s sequence-verified but flags an unwanted immune response downstream. We’ve seen it, and helped fix it.

At Creative Biolabs, we specialize in resolving these challenges through a robust portfolio of binding analysis, sequence validation, immunogenicity profiling, and biophysical testing. Our scientists work hand-in-hand with your team to ensure your candidate is functionally sound, structurally correct, and ready for the next stage. Whether you’re rescuing a hybridoma, troubleshooting loss of specificity, or ensuring off-target risks are under control—we’ve got the tools, insights, and experience to help you move forward with confidence.

Scientists in a modern laboratory discussing results. Fig.2

Why Partner with Creative Biolabs

Full-Stack Characterization Expertise

From binding and biophysical testing to immunogenicity prediction, we cover every angle of your antibody.

Tailored to Your Format

scFv, Fab, full IgG, bispecifics, or VHH—we customize our workflows for your molecule type.

Data You Can Rely On

High-resolution data, reproducible results, and publication-ready figures come standard with every project.

Next-Level Off-Target Profiling

Our membrane proteome array screens over 6,000 human proteins to catch even the rarest interactions.

Innovators Partnering with Creative Biolabs

How We Characterize Your Molecule Step by Step

1

Kickoff & Consultation

We start with a deep-dive discussion to understand your molecule, concerns, and development goals. Whether you’re focused on sequence fidelity, immunogenicity, or binding data—we align the strategy upfront.

2

Platform Selection & Assay Design

Based on your format and project stage, we’ll design a fit-for-purpose workflow using SPR, ITC, DSC, sequencing, or cell-based immunogenicity systems.

3

Experimental Execution

All tests are conducted under strict SOPs with QC checkpoints. You’ll receive real-time updates and have direct communication with your assigned project lead.

4

Data Delivery & Follow-Up

Expect a comprehensive report including raw data, curated figures, assay interpretation, and actionable insights for your next step. Follow-up consultation is always included.

Welcome to Creative Biolabs' Characterization Services

How does it bind? How strong is the interaction? Is it really specific?

See Binding Insights

Do you really know what’s in your antibody? Let’s make sure.

Go to Sequence Services

What if your "perfect" antibody triggers an immune response?

Assess Immunogenicity Risk

Is your antibody stable, functional, and ready for scale-up?

Test Biophysical Properties

Binding Analysis

These are the kinds of questions that make or break therapeutic candidates. That’s why our binding analysis services focus on unraveling every layer of the antigen–antibody interaction. We offer a complete suite of binding studies that reveal how your molecule behaves in real-world biological contexts, from high-affinity measurements to detailed epitope profiling and off-target screening.

Sequence Analysis

Your antibody’s sequence is its blueprint, and any uncertainty could mean big trouble down the line. Whether you’re working with a mysterious hybridoma, a partially lost sequence, or a novel recombinant format, our sequencing experts are here to help you get the complete picture. You’ll receive annotated, publication-ready files—including CDR identification, IMGT numbering, and detailed sequence alignments. It's more than raw data, it's clarity, confidence, and continuity for your project.

Immunogenicity Analysis

Immunogenicity risk is one of the biggest hurdles in therapeutic antibody development. We’re here to help you stay ahead of it, with proactive, data-driven assessments that help you predict and mitigate immune responses early on. All services are designed for research use only and tailored for preclinical optimization, because catching issues now saves you costly surprises later.

Property Analysis

Biophysical characterization is essential for formulation development, comparability studies, and developability assessments. We use a variety of high-precision tools to measure how your antibody behaves under stress, how it folds, and how it interacts with its environment.

Hot Products & Services You Might Need

Featured Products

Engineering Services for Better Biologics

At Creative Biolabs, we don't stop at characterization. Once you've identified bottlenecks like low affinity, instability, or immunogenic hotspots, our protein and antibody engineering services are here to fix them. Whether you need to convert an scFv into a full-length IgG or enhance the biophysical robustness of your molecule, we have you covered. Our reformatting & isotype switching solutions help adapt your antibody to different assay platforms, therapeutic formats, or animal models without compromising function. Meanwhile, our property optimization suite fine-tunes key traits such as thermal stability, aggregation resistance, and target selectivity. These engineering solutions seamlessly integrate with our characterization insights, offering you a powerful one-stop solution from problem to performance.

Frequently Asked Questions

I already have binding data. Do I still need full characterization?

Yes, and here's why. Binding affinity alone doesn’t predict immunogenicity, structural integrity, or stability. We've seen binders that perform well in vitro but fail later due to sequence issues or developability flaws. A full profile saves time and cost downstream.

How much antibody sample is required for testing?

Most assays require 100–500 µg of purified antibody, but we’re flexible. If you only have hybridoma supernatant or limited quantity, we can often adjust protocols. Just let us know what you have—we’ll find the most efficient path forward.

Will I receive support interpreting the results?

Definitely. You’ll get a complete report with all raw data, graphs, and our expert interpretation. We’ll also schedule a follow-up session to walk through the findings and discuss how they impact your development plan.

Can I combine multiple assays in a single project?

Yes! We routinely bundle binding, immunogenicity, and developability tests to save time and budget. Our team will design an integrated workflow that fits your goals and timelines, with no redundant steps or delays.

How quickly can I expect to receive the final results?

Most standard assays are completed within 5–10 business days from sample receipt. More advanced studies like DSC or proteome arrays may take 2–3 weeks. Either way, we provide a detailed timeline upfront—no surprises.


×
Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Related Sections
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us